5.37
price down icon3.50%   -0.195
 
loading

Kyntra Bio Inc Stock (KYNB) Forecast

The Kyntra Bio Inc (KYNB) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.591, representing a -14.51% decrease from the current price of $5.37. The highest analyst price target is $5.538, and the lowest is $3.644.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month KYNB Price Target
Average 3.1355 (-41.61% Downside)
loading

Is Kyntra Bio Inc (KYNB) A Buy Now?

Oscillators
Name Value Action
RSI(14) 21.67 Buy
STOCH(9,6) 21.62 Neutral
STOCHRSI(14) 1.9403 Buy
MACD(12,26) -0.4804 Sell
ADX(14) 50.12 Sell
William %R -98.31 Buy
CCI(14) -82.04 Neutral
Buy: 3 Sell: 2 Neutral: 2
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
5.9485
Sell
5.9698
Sell
MA20
6.4535
Sell
6.375
Sell
MA50
7.1716
Sell
6.8771
Sell
MA100
7.1108
Sell
7.0962
Sell
MA200
7.0672
Sell
0.00
Buy
Buy: 1 Sell: 9 Neutral: 0
Summary: Sell
According to our latest analysis, KYNB could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on KYNB, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 21.67 indicates that KYNB is oversold. This indicates that KYNB price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
  2. STOCH (Stochastic Oscillator): The STOCH value of 21.62 indicates that KYNB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 1.9403 indicates that KYNB is oversold. This suggests that KYNB price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 50.12 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -82.04 indicates that KYNB is still oversold but not to an extreme extent.

Long-term KYNB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Kyntra Bio Inc financial reports and earnings history, Kyntra Bio Inc (KYNB) stock could reach $3.4082 by 2030, $48.78 by 2040 and $78.47 by 2050. See the projected annual prices until 2050 of the Kyntra Bio Inc stock below:

  • Kyntra Bio Inc (KYNB) is expected to reach an average price of $23.79 in 2035, with a high prediction of $24.75 and a low estimate of $23.82. This indicates an $343.02% rise from the last recorded price of $5.37.
  • Kyntra Bio Inc (KYNB) stock is projected to chart a bullish course in 2040, with an average price target of $49.09, representing an $814.12% surge from its current level. The forecast ranges from a conservative $28.10 to a sky-high $48.78.
  • Our analysts predict Kyntra Bio Inc (KYNB) to jump 779.24% by 2045, soaring from $47.36 to an average price of $47.22, potentially reaching $49.23. While $47.36 is the low estimate, the potential upside is significant.
  • Kyntra Bio Inc (KYNB) stock is expected to climb by 2050, reaching an average of $75.58, a $1,307% jump from its current level. However, a wide range of estimates exists, with high and low targets of $78.47 and $75.58, respectively, highlighting the market's uncertainty.

Kyntra Bio Inc Stock (KYNB) Year by Year Forecast

Kyntra Bio Inc Stock (KYNB) Price Forecast for 2026

The predicted value for Kyntra Bio Inc (KYNB) in 2026 is set at an average of $6.4835. Estimates vary from a peak of $9.70 to a trough of $3.267, indicating an +20.74% surge from the present price of $5.37.
Month Average Low High Change from today's price
November, 2026 $4.854 $3.644 $5.538 -9.61%
December, 2026 $3.79 $3.267 $5.1492 -29.42%

Kyntra Bio Inc Stock (KYNB) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Kyntra Bio Inc (KYNB) is $3.1109, with a high forecast of $6.2119 and a low forecast of $0.00996. This indicates an -42.07% decrease from the last price of $5.37.
Month Average Low High Change from today's price
January, 2027 $3.956 $3.043 $4.176 -26.33%
February, 2027 $4.002 $3.809 $4.2725 -25.48%
March, 2027 $3.7795 $3.7195 $4.2502 -29.62%
April, 2027 $4.7455 $3.651 $5.051 -11.63%
May, 2027 $4.0829 $4.0129 $5.0784 -23.97%
June, 2027 $5.4989 $4.1344 $5.6289 +2.40%
July, 2027 $4.6799 $4.2649 $6.2119 -12.85%
August, 2027 $3.3274 $3.2224 $4.9364 -38.04%
September, 2027 $0.759 $0.364 $2.39 -85.87%
October, 2027 $0.061 $0.059 $2.058 -98.86%
November, 2027 $0.226 $0.00996 $0.907 -95.79%
December, 2027 $0.8379 $0.259 $1.0899 -84.40%

Kyntra Bio Inc Stock (KYNB) Price Forecast for 2028

In 2028, Kyntra Bio Inc (KYNB) is projected to reach an average price of $2.2519, with a high projection of $3.7539 and a low estimate of $0.7499. This indicates an -58.07% fall from the last price of $5.37.
Month Average Low High Change from today's price
January, 2028 $1.0029 $0.7499 $1.1936 -81.32%
February, 2028 $0.9649 $0.7519 $2.1519 -82.03%
March, 2028 $2.1219 $1.0379 $2.3369 -60.49%
April, 2028 $2.0389 $1.3659 $2.2649 -62.03%
May, 2028 $3.6339 $1.7049 $3.7539 -32.33%
June, 2028 $1.9859 $1.8699 $3.6469 -63.02%
July, 2028 $1.7305 $0.9848 $2.2388 -67.77%
August, 2028 $3.0425 $2.353 $1.8625 -43.34%
September, 2028 $3.1445 $3.288 $3.0082 -41.44%
October, 2028 $2.4721 $2.8221 $2.8911 -53.97%
November, 2028 $2.1741 $2.204 $2.0926 -59.51%
December, 2028 $1.9861 $2.0361 $1.9306 -63.01%

Kyntra Bio Inc Stock (KYNB) Price Forecast for 2029

The 2029 price forecast for Kyntra Bio Inc Stock (KYNB) is $3.249 on average, with a high prediction of $6.4113 and a low estimate of $0.0868. This represents an -39.50% decrease from the previous price of $5.37.
Month Average Low High Change from today's price
January, 2029 $0.8636 $1.5436 $1.8016 -83.92%
February, 2029 $1.0057 $0.9491 $0.6485 -81.27%
March, 2029 $0.1377 $0.8422 $0.7612 -97.44%
April, 2029 $0.1102 $0.0868 $1.2958 -97.95%
May, 2029 $0.6972 $0.1907 $0.3572 -87.02%
June, 2029 $5.628 $1.2527 $5.238 +4.80%
July, 2029 $6.808 $6.616 $5.366 +26.78%
August, 2029 $6.6441 $6.6701 $6.4113 +23.73%
September, 2029 $5.4101 $5.7101 $6.1681 +0.75%
October, 2029 $5.2801 $5.2761 $5.2241 -1.67%
November, 2029 $4.4662 $4.9982 $4.9241 -16.83%
December, 2029 $3.3612 $3.7162 $4.2702 -37.41%

Kyntra Bio Inc Stock (KYNB) Price Forecast for 2030

Kyntra Bio Inc Stock (KYNB) is expected to reach an average price of $5.9233 in 2030, with a high forecast of $9.8143 and a low forecast of $2.0323. This signifies an +10.30% surge from the last price of $5.37.
Month Average Low High Change from today's price
January, 2030 $3.1922 $3.6802 $3.4082 -40.55%
February, 2030 $2.1783 $2.3633 $2.9288 -59.44%
March, 2030 $2.5143 $2.0323 $2.1543 -53.18%
April, 2030 $9.055 $2.7283 $8.575 +68.62%
May, 2030 $9.425 $9.0975 $8.895 +75.51%
June, 2030 $10.18 $10.17 $9.8143 +89.48%
July, 2030 $9.2176 $9.4776 $9.4451 +71.65%
August, 2030 $8.3277 $8.5736 $8.6801 +55.08%
September, 2030 $7.9102 $7.9602 $8.1502 +47.30%
October, 2030 $6.9402 $7.4702 $7.6627 +29.24%
November, 2030 $6.3203 $6.3903 $6.3538 +17.70%
December, 2030 $5.2428 $5.9528 $6.0553 -2.37%
$7.51
price up icon 1.49%
$10.27
price up icon 0.39%
$5.745
price up icon 5.12%
$18.92
price up icon 5.11%
$10.89
price up icon 5.83%
WVE WVE
$3.185
price up icon 3.07%
Cap:     |  Volume (24h):